Ever Source Wealth Advisors, LLC Arcus Biosciences, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 304 shares of RCUS stock, worth $5,310. This represents 0.0% of its overall portfolio holdings.
Number of Shares
304
Previous 15
1926.67%
Holding current value
$5,310
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RCUS
# of Institutions
212Shares Held
67MCall Options Held
3.18MPut Options Held
167K-
Black Rock Inc. New York, NY9.76MShares$171 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.56MShares$115 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.97MShares$104 Million0.11% of portfolio
-
Woodline Partners LP San Francisco, CA4MShares$69.9 Million0.19% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$64.4 Million1.03% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.26B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...